Experimental results confirmed that DLC1 downregulation promotes the cadherin switch in mesenchymal cells upon TGFβ withdrawal, thus potentially providing an advantage to metastatic cancer cells during colonization of distant organs. This evidence concerns the gene CDH17 and cancer.